Skip to main content
FTRE
NASDAQ Life Sciences

Fortrea Reinstates CFO Knoblauch After Settling Non-Compete Lawsuit

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$16.79
Mkt Cap
$1.597B
52W Low
$8.305
52W High
$21.39
52W Position info
102% above low
Off High info
22% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

FTRE has more than doubled off its 52-week low of $8.305.

Summary

Fortrea has reinstated Jason Knoblauch as CFO after settling the non-compete lawsuit that had sidelined him since July. The temporary restraining order from his former employer, Clario, has been lifted, allowing him to resume the role. Interim CFO David Smith, a board director, will step back. This resolves a key leadership uncertainty that had been hanging over the company since the court order in late July. The reinstatement follows the company's strong Q2 results and the recent $45M acquisition of Worldwide Clinical Trials' Early Phase Services division, suggesting management stability is being restored.

At the time of this announcement, FTRE was trading at $16.79 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $8.31 to $21.39. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

FTRE - Latest Insights

FTRE
Oct 29, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $23.14
Real-time Price: $19.79 info
Change: -$3.35 (-14%) info
Market Cap: $1.91B info
FTRE
Oct 29, 2026, 6:38 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.77
Real-time Price: $19.79 info
Change: -$5.98 (-23%) info
Market Cap: $1.91B info
FTRE
Oct 29, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $25.80
Real-time Price: $19.79 info
Change: -$6.01 (-23%) info
Market Cap: $1.91B info
FTRE
Sep 10, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $16.79
Real-time Price: $19.79 info
Change: +$3.00 (+18%) info
Market Cap: $1.91B info
FTRE
Sep 02, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $17.72
Real-time Price: $19.79 info
Change: +$2.07 (+12%) info
Market Cap: $1.91B info